Quarterly Results

NEXUS SURGICAL AND MEDICARE LTD.

NSE : NABSE : 538874ISIN CODE : INE370Q01015Industry : Finance - Stock BrokingHouse : Private
BSE12.66-0.66 (-4.95 %)
PREV CLOSE ( ) 13.32
OPEN PRICE ( ) 13.32
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3338
TODAY'S LOW / HIGH ( )12.66 13.32
52 WK LOW / HIGH ( ) 8.117.45
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
Audited
Net Sales
14.46
3.7
10.61
1.39
Total Expenditure
13.89
2.78
10.32
2.7
PBIDT (Excl OI)
0.57
0.92
0.28
-1.31
Other Income
0.06
0.19
0.08
NA
Operating Profit
0.62
1.1
0.36
-1.31
Interest
NA
NA
NA
NA
Exceptional Items
NA
NA
NA
NA
PBDT
0.62
1.1
0.36
-1.31
Depreciation
0.01
0.00
NA
0.00
Profit Before Tax
0.61
1.1
0.36
-1.31
Tax
0.16
0.28
0.09
-0.32
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
0.45
0.82
0.27
-0.99
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
0.45
0.82
0.27
-0.99
Equity Capital
54.72
54.72
54.72
54.72
Face Value (IN RS)
10
10
10
10
Reserves
Calculated EPS
0.08
0.14
0.04
-0.18
Calculated EPS (Annualised)
0.33
0.59
0.19
-0.72
No of Public Share Holdings
4446900
4446900
4446900
4446900
% of Public Share Holdings
81.27
81.27
81.27
81.27
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
3.94
24.86
2.73
-94.24
PBIDTM%
4.35
29.72
3.39
-94.24
PBDTM%
4.35
29.72
3.39
-94.24
PBTM%
4.28
29.72
3.39
-94.24
PATM%
3.18
22.16
2.54
-71.22
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.